ESSA Pharma Inc. Common Stock

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. Shares of Booz Allen Hamilton Holding Corporation (NYSE: BAH) rose sharply during Friday’s session after the company reported better-than-expected third-quarter financial results, increased its quarterly dividend and raised FY24 guidance. Booz Allen Hamilton posted adjusted earnings of $1.41 per share, beating market estimates of $1.14 per share. The company’s quarterly sales came in at $2.57 billion versus expectations of $2.54 billion, according to data from Benzinga Pro. Booz Allen Hamilton shares jumped 13.2% to $145.90 on Friday. Here are some other big stocks recording gains in today’s session. AppFolio, Inc. (NASDAQ: APPF) surged 25.7% to $219.23 after the company reported better-than-expected fourth-quarter financial results and issued guidance. Vera Therapeutics, Inc. (NASDAQ: VERA) gained 20.6% to $30.54. Raymond James analyst Steven Seedhouse upgraded ...

Related tickers: TELL, CDMO, AVTR, FRHC, EHTH, LUMN, EPIX, CIFR, FFIN, GNTX, RGEN, TBBK, AXP, OLN, BAH, VERA, MREO, APPF, CLSK.

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance. The company reported a Q4 adjusted loss of 11 cents per share, a turnaround from EPS income of $1.97 per share a year ago, missing the consensus for a loss of 5 cents per share. The insurer reported adjusted revenue of $25.73 billion, compared to $21.30 billion a year ago and the consensus of $25.55 billion. Humana shares dipped 11.3% to $356.93 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Onconetix, Inc. (NASDAQ: ONCO) shares surged 137% to $0.3519 after falling over 4% on Wednesday. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) gained 97% to $4.0527 after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Enviva Inc. (NYSE: EVA) climbed 47.4% to $0.5239. Vera Therapeutics, Inc. (NASDAQ: VERA) shares jumped 46% to $24.84 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Rail Vision Ltd. (NASDAQ: RVSN) gained 43.8% to $7.78. Foresight's affiliate Rail Vision's Main Line System secured EU Railway Standards approval and certifications. LAVA Therapeutics N.V. (NASDAQ: LVTX) rose 37.4% to $2.13 after the company announced a clinical trial collaboration and supply agreement with Merck & Co. to evaluate LAVA-1207 in combination with KEYTRUDA. Acutus Medical, Inc. (NASDAQ: AFIB) shares climbed 30.6% to $0.29. Acutus Medical has been granted European patent number EP3043701 titled "Devices and Methods for Determination of Electrical Dipole Densities on a Cardiac Surface (And Methods for Diagnosing Tissue Health)." Prairie Operating Co. (NASDAQ: PROP) gained 28.8% to $8.17. American Superconductor Corporation (NASDAQ: AMSC) shares climbed 28.4% to $12.52 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates. CCSC ...

Related tickers: RDHL, MRAI, MPX, AAL, IMMX, NOK, NEP, ALTI, CCTG, ORI, RR, AMSC, CISS, POL, VIRT, COLB, VSME, TAL, CNXC, EPIX, URI, EVA, RVSN, WRB, AKTS, ALK, XRX, INSG, ATI, TSLA, CMND, CRS, VERA, PCSA, CYN, ALPN, HUT, HUM, PHUN, RXT, HXL, PROP, ONCO, AFIB, HZO, CRGE, LVTX, IBM, ADT, BMEA, LPL.